サマリー

非注射用医薬品添加剤の世界市場規模は、2022年の4580.2百万米ドルから2029年には8961百万米ドルに成長すると予測され、2023年から2029年までのCAGRは10.1％と予測されています。
非注射用医薬品添加剤の米国市場は、2023年から2029年までのCAGRで、2022年の100万米ドルから2029年には100万米ドルに増加すると推定されています。
非注射用医薬品の中国市場は、2023年から2029年までの年平均成長率で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
非注射用医薬品のヨーロッパ市場は、2023年から2029年までの年平均成長率で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
世界の主要な非注射用医薬品賦形剤は、ダウ、日本ファインケミカル、南京ウェル製薬、江蘇マキシム生物、NOF、クロダ、江蘇ポリ製薬、二康製薬、広州漢方製薬などです。収益面では、世界の大手2社が2022年にほぼ％のシェアを占めています。
医薬品賦形剤とは、医薬品の安定性、バイオアベイラビリティ、口当たり、その他の特性を改善するために製剤に添加される非活性物質です。規制当局によって一般的に安全とみなされる（GRAS）もので、錠剤、カプセル、内服液、外用クリーム、吸入器など、さまざまな剤形に使用されています。
LPI（エルピーアイ）の最新調査レポート「非注射用医薬品の業界予測」は、過去の売上高から2022年の世界の非注射用医薬品の総売上高を検討し、2023年から2029年の非注射用医薬品の売上高予測について地域や市場分野ごとに包括的な分析を提供しています。非注射用医薬品の売上高を地域別、市場分野別、サブセクター別に分類し、世界の非注射用医薬品業界の詳細な分析（百万米ドル）を提供します。
本インサイトレポートでは、世界の非注射用医薬品添加剤の状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにします。また、本レポートでは、加速する世界の非注射用医薬品の市場において、これらの企業の独自のポジションをより良く理解するために、非注射用医薬品のポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、主要グローバル企業の戦略を分析しています。
本インサイトレポートでは、非注射用医薬品添加剤の世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、この調査予測は、世界の非注射用医薬品添加剤の現状と将来の軌道について非常にニュアンスのある見方を提供します。
本レポートでは、非注射用医薬品添加剤市場の製品タイプ、用途、主要メーカー、主要地域、国別の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメント
結合剤
崩壊剤（Disintegrants
滑沢剤
充填剤
その他
用途別セグメント
錠剤
カプセル剤
内服液剤
その他
また、本レポートでは、地域別に市場を分割しています：
米州
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中近東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報に基づいて選択されており、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析したものである。
ダウ
日本ファインケミカル
南京ウェル製薬
江蘇マキシムバイオロジカル（Jiangsu Maxim Biological
日油
クロダ
江蘇ポリ製薬
二康製薬
広州漢方製薬
プファンスティール
西安リバング製薬
浙江省天宇山薬用オイル
本レポートで取り上げる主な質問
世界の非注射用医薬品添加剤市場の10年後の展望は？
世界および地域別に、非注射用医薬品添加剤市場の成長を促進する要因は何か？
市場別、地域別に最も速い成長を遂げる技術は何か？
非注射用医薬品添加剤の市場機会は、最終市場規模によってどのように変化するか？
非注射用医薬品添加剤のタイプ別、用途別内訳は？
COVID-19とロシア・ウクライナ戦争の影響とは？

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pharmaceutical Excipients for Non-injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pharmaceutical Excipients for Non-injection by Country/Region, 2018, 2022 & 2029
2.2 Pharmaceutical Excipients for Non-injection Segment by Type
2.2.1 Binders
2.2.2 Disintegrants
2.2.3 Lubricants
2.2.4 Fillers
2.2.5 Others
2.3 Pharmaceutical Excipients for Non-injection Sales by Type
2.3.1 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023)
2.3.2 Global Pharmaceutical Excipients for Non-injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Type (2018-2023)
2.4 Pharmaceutical Excipients for Non-injection Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Oral Liquids
2.4.4 Others
2.5 Pharmaceutical Excipients for Non-injection Sales by Application
2.5.1 Global Pharmaceutical Excipients for Non-injection Sale Market Share by Application (2018-2023)
2.5.2 Global Pharmaceutical Excipients for Non-injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Application (2018-2023)
3 Global Pharmaceutical Excipients for Non-injection by Company
3.1 Global Pharmaceutical Excipients for Non-injection Breakdown Data by Company
3.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Company (2018-2023)
3.1.2 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company (2018-2023)
3.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Company (2018-2023)
3.2.1 Global Pharmaceutical Excipients for Non-injection Revenue by Company (2018-2023)
3.2.2 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company (2018-2023)
3.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Excipients for Non-injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Excipients for Non-injection Product Location Distribution
3.4.2 Players Pharmaceutical Excipients for Non-injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pharmaceutical Excipients for Non-injection by Geographic Region
4.1 World Historic Pharmaceutical Excipients for Non-injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pharmaceutical Excipients for Non-injection Market Size by Country/Region (2018-2023)
4.2.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pharmaceutical Excipients for Non-injection Sales Growth
4.4 APAC Pharmaceutical Excipients for Non-injection Sales Growth
4.5 Europe Pharmaceutical Excipients for Non-injection Sales Growth
4.6 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Growth
5 Americas
5.1 Americas Pharmaceutical Excipients for Non-injection Sales by Country
5.1.1 Americas Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023)
5.1.2 Americas Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023)
5.2 Americas Pharmaceutical Excipients for Non-injection Sales by Type
5.3 Americas Pharmaceutical Excipients for Non-injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Excipients for Non-injection Sales by Region
6.1.1 APAC Pharmaceutical Excipients for Non-injection Sales by Region (2018-2023)
6.1.2 APAC Pharmaceutical Excipients for Non-injection Revenue by Region (2018-2023)
6.2 APAC Pharmaceutical Excipients for Non-injection Sales by Type
6.3 APAC Pharmaceutical Excipients for Non-injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharmaceutical Excipients for Non-injection by Country
7.1.1 Europe Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023)
7.1.2 Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023)
7.2 Europe Pharmaceutical Excipients for Non-injection Sales by Type
7.3 Europe Pharmaceutical Excipients for Non-injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Excipients for Non-injection by Country
8.1.1 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Type
8.3 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Non-injection
10.3 Manufacturing Process Analysis of Pharmaceutical Excipients for Non-injection
10.4 Industry Chain Structure of Pharmaceutical Excipients for Non-injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Excipients for Non-injection Distributors
11.3 Pharmaceutical Excipients for Non-injection Customer
12 World Forecast Review for Pharmaceutical Excipients for Non-injection by Geographic Region
12.1 Global Pharmaceutical Excipients for Non-injection Market Size Forecast by Region
12.1.1 Global Pharmaceutical Excipients for Non-injection Forecast by Region (2024-2029)
12.1.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pharmaceutical Excipients for Non-injection Forecast by Type
12.7 Global Pharmaceutical Excipients for Non-injection Forecast by Application
13 Key Players Analysis
13.1 Dow
13.1.1 Dow Company Information
13.1.2 Dow Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.1.3 Dow Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Dow Main Business Overview
13.1.5 Dow Latest Developments
13.2 Nippon Fine Chemical
13.2.1 Nippon Fine Chemical Company Information
13.2.2 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.2.3 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Nippon Fine Chemical Main Business Overview
13.2.5 Nippon Fine Chemical Latest Developments
13.3 Nanjing Well Pharmaceutical
13.3.1 Nanjing Well Pharmaceutical Company Information
13.3.2 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.3.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Nanjing Well Pharmaceutical Main Business Overview
13.3.5 Nanjing Well Pharmaceutical Latest Developments
13.4 Jiangsu Maxim Biological
13.4.1 Jiangsu Maxim Biological Company Information
13.4.2 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.4.3 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Jiangsu Maxim Biological Main Business Overview
13.4.5 Jiangsu Maxim Biological Latest Developments
13.5 NOF
13.5.1 NOF Company Information
13.5.2 NOF Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.5.3 NOF Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 NOF Main Business Overview
13.5.5 NOF Latest Developments
13.6 Croda
13.6.1 Croda Company Information
13.6.2 Croda Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.6.3 Croda Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Croda Main Business Overview
13.6.5 Croda Latest Developments
13.7 Jiangsu Poly Pharmaceutical
13.7.1 Jiangsu Poly Pharmaceutical Company Information
13.7.2 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.7.3 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Jiangsu Poly Pharmaceutical Main Business Overview
13.7.5 Jiangsu Poly Pharmaceutical Latest Developments
13.8 Er Kang Pharmaceutical
13.8.1 Er Kang Pharmaceutical Company Information
13.8.2 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.8.3 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Er Kang Pharmaceutical Main Business Overview
13.8.5 Er Kang Pharmaceutical Latest Developments
13.9 Guangzhou Hanfang Pharmaceutical
13.9.1 Guangzhou Hanfang Pharmaceutical Company Information
13.9.2 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.9.3 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Guangzhou Hanfang Pharmaceutical Main Business Overview
13.9.5 Guangzhou Hanfang Pharmaceutical Latest Developments
13.10 Pfanstiehl
13.10.1 Pfanstiehl Company Information
13.10.2 Pfanstiehl Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.10.3 Pfanstiehl Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Pfanstiehl Main Business Overview
13.10.5 Pfanstiehl Latest Developments
13.11 Xi'an Libang Pharmaceutical
13.11.1 Xi'an Libang Pharmaceutical Company Information
13.11.2 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.11.3 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Xi'an Libang Pharmaceutical Main Business Overview
13.11.5 Xi'an Libang Pharmaceutical Latest Developments
13.12 Zhejiang Tianyushan Medicinal Oil
13.12.1 Zhejiang Tianyushan Medicinal Oil Company Information
13.12.2 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.12.3 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Zhejiang Tianyushan Medicinal Oil Main Business Overview
13.12.5 Zhejiang Tianyushan Medicinal Oil Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. Pharmaceutical Excipients for Non-injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pharmaceutical Excipients for Non-injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Binders
Table 4. Major Players of Disintegrants
Table 5. Major Players of Lubricants
Table 6. Major Players of Fillers
Table 7. Major Players of Others
Table 8. Global Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units)
Table 9. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023)
Table 10. Global Pharmaceutical Excipients for Non-injection Revenue by Type (2018-2023) & ($ million)
Table 11. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2018-2023)
Table 12. Global Pharmaceutical Excipients for Non-injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units)
Table 14. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023)
Table 15. Global Pharmaceutical Excipients for Non-injection Revenue by Application (2018-2023)
Table 16. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2018-2023)
Table 17. Global Pharmaceutical Excipients for Non-injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Pharmaceutical Excipients for Non-injection Sales by Company (2018-2023) & (K Units)
Table 19. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company (2018-2023)
Table 20. Global Pharmaceutical Excipients for Non-injection Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company (2018-2023)
Table 22. Global Pharmaceutical Excipients for Non-injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Pharmaceutical Excipients for Non-injection Producing Area Distribution and Sales Area
Table 24. Players Pharmaceutical Excipients for Non-injection Products Offered
Table 25. Pharmaceutical Excipients for Non-injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Pharmaceutical Excipients for Non-injection Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Pharmaceutical Excipients for Non-injection Sales Market Share Geographic Region (2018-2023)
Table 30. Global Pharmaceutical Excipients for Non-injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Pharmaceutical Excipients for Non-injection Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Country/Region (2018-2023)
Table 34. Global Pharmaceutical Excipients for Non-injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) & (K Units)
Table 37. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2018-2023)
Table 38. Americas Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2018-2023)
Table 40. Americas Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units)
Table 41. Americas Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units)
Table 42. APAC Pharmaceutical Excipients for Non-injection Sales by Region (2018-2023) & (K Units)
Table 43. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2018-2023)
Table 44. APAC Pharmaceutical Excipients for Non-injection Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2018-2023)
Table 46. APAC Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units)
Table 47. APAC Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units)
Table 48. Europe Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) & (K Units)
Table 49. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2018-2023)
Table 50. Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2018-2023)
Table 52. Europe Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units)
Table 53. Europe Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Pharmaceutical Excipients for Non-injection
Table 61. Key Market Challenges & Risks of Pharmaceutical Excipients for Non-injection
Table 62. Key Industry Trends of Pharmaceutical Excipients for Non-injection
Table 63. Pharmaceutical Excipients for Non-injection Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Pharmaceutical Excipients for Non-injection Distributors List
Table 66. Pharmaceutical Excipients for Non-injection Customer List
Table 67. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Pharmaceutical Excipients for Non-injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Pharmaceutical Excipients for Non-injection Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Pharmaceutical Excipients for Non-injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Pharmaceutical Excipients for Non-injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Dow Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 82. Dow Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 83. Dow Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Dow Main Business
Table 85. Dow Latest Developments
Table 86. Nippon Fine Chemical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 87. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 88. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Nippon Fine Chemical Main Business
Table 90. Nippon Fine Chemical Latest Developments
Table 91. Nanjing Well Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 92. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 93. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Nanjing Well Pharmaceutical Main Business
Table 95. Nanjing Well Pharmaceutical Latest Developments
Table 96. Jiangsu Maxim Biological Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 97. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 98. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Jiangsu Maxim Biological Main Business
Table 100. Jiangsu Maxim Biological Latest Developments
Table 101. NOF Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 102. NOF Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 103. NOF Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. NOF Main Business
Table 105. NOF Latest Developments
Table 106. Croda Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 107. Croda Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 108. Croda Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Croda Main Business
Table 110. Croda Latest Developments
Table 111. Jiangsu Poly Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 112. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 113. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Jiangsu Poly Pharmaceutical Main Business
Table 115. Jiangsu Poly Pharmaceutical Latest Developments
Table 116. Er Kang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 117. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 118. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Er Kang Pharmaceutical Main Business
Table 120. Er Kang Pharmaceutical Latest Developments
Table 121. Guangzhou Hanfang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 122. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 123. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Guangzhou Hanfang Pharmaceutical Main Business
Table 125. Guangzhou Hanfang Pharmaceutical Latest Developments
Table 126. Pfanstiehl Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 127. Pfanstiehl Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 128. Pfanstiehl Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Pfanstiehl Main Business
Table 130. Pfanstiehl Latest Developments
Table 131. Xi'an Libang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 132. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 133. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Xi'an Libang Pharmaceutical Main Business
Table 135. Xi'an Libang Pharmaceutical Latest Developments
Table 136. Zhejiang Tianyushan Medicinal Oil Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 137. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 138. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Zhejiang Tianyushan Medicinal Oil Main Business
Table 140. Zhejiang Tianyushan Medicinal Oil Latest Developments
List of Figures
Figure 1. Picture of Pharmaceutical Excipients for Non-injection
Figure 2. Pharmaceutical Excipients for Non-injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Excipients for Non-injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pharmaceutical Excipients for Non-injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pharmaceutical Excipients for Non-injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Binders
Figure 10. Product Picture of Disintegrants
Figure 11. Product Picture of Lubricants
Figure 12. Product Picture of Fillers
Figure 13. Product Picture of Others
Figure 14. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type in 2022
Figure 15. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2018-2023)
Figure 16. Pharmaceutical Excipients for Non-injection Consumed in Tablets
Figure 17. Global Pharmaceutical Excipients for Non-injection Market: Tablets (2018-2023) & (K Units)
Figure 18. Pharmaceutical Excipients for Non-injection Consumed in Capsules
Figure 19. Global Pharmaceutical Excipients for Non-injection Market: Capsules (2018-2023) & (K Units)
Figure 20. Pharmaceutical Excipients for Non-injection Consumed in Oral Liquids
Figure 21. Global Pharmaceutical Excipients for Non-injection Market: Oral Liquids (2018-2023) & (K Units)
Figure 22. Pharmaceutical Excipients for Non-injection Consumed in Others
Figure 23. Global Pharmaceutical Excipients for Non-injection Market: Others (2018-2023) & (K Units)
Figure 24. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2022)
Figure 25. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application in 2022
Figure 26. Pharmaceutical Excipients for Non-injection Sales Market by Company in 2022 (K Units)
Figure 27. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company in 2022
Figure 28. Pharmaceutical Excipients for Non-injection Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company in 2022
Figure 30. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Pharmaceutical Excipients for Non-injection Sales 2018-2023 (K Units)
Figure 33. Americas Pharmaceutical Excipients for Non-injection Revenue 2018-2023 ($ Millions)
Figure 34. APAC Pharmaceutical Excipients for Non-injection Sales 2018-2023 (K Units)
Figure 35. APAC Pharmaceutical Excipients for Non-injection Revenue 2018-2023 ($ Millions)
Figure 36. Europe Pharmaceutical Excipients for Non-injection Sales 2018-2023 (K Units)
Figure 37. Europe Pharmaceutical Excipients for Non-injection Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue 2018-2023 ($ Millions)
Figure 40. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Country in 2022
Figure 41. Americas Pharmaceutical Excipients for Non-injection Revenue Market Share by Country in 2022
Figure 42. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023)
Figure 43. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023)
Figure 44. United States Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Region in 2022
Figure 49. APAC Pharmaceutical Excipients for Non-injection Revenue Market Share by Regions in 2022
Figure 50. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023)
Figure 51. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023)
Figure 52. China Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Country in 2022
Figure 60. Europe Pharmaceutical Excipients for Non-injection Revenue Market Share by Country in 2022
Figure 61. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023)
Figure 62. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023)
Figure 63. Germany Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023)
Figure 72. Egypt Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Non-injection in 2022
Figure 78. Manufacturing Process Analysis of Pharmaceutical Excipients for Non-injection
Figure 79. Industry Chain Structure of Pharmaceutical Excipients for Non-injection
Figure 80. Channels of Distribution
Figure 81. Global Pharmaceutical Excipients for Non-injection Sales Market Forecast by Region (2024-2029)
Figure 82. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Pharmaceutical Excipients for Non-injection Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Pharmaceutical Excipients for Non-injection Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Application (2024-2029)